Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer

Table 6

Outcomes report by study.

Author	5 yr OS	5 yr PFS	Other	1A	1B	1C
Bristow et al. [28]	82%
Carcangiu et al. [33]	83%
Dietrich et al. [34]		85.7% platinum + cyclo or platinum alone100% for carbo + taxol
Fields et al. [32]			3 yr OS 75%; 3 yr DFS 69%
Grice et al. [43]	84%		48 mos′
Huh et al. [29]	72%	70%
Havrilesky et al. [39]			Rads only; 3 yr OS 63%; 3 yr PFS 44%	3 yr OS 95%, PFS 85%	3 yr OS 69%, PFS 59%	3 yr OS 79%, PFS 60%
Kelly et al. [40]				51 mos′	37 mos′	44 mos′
Low et al. [45]	73%
Piura et al. [46]			83.3% 3 yr for 10 patients only 7 surgically staged	34 mos′	46 mos′	35 mos′
Slomovitz et al. [47]	63%			5 yr OS 81.5%	5 yr OS 58.6%	5 yr OS 34.3%
Thomas et al. [41]	85%	78%		5 yr OS 100%	5 yr OS 89%	5 yr OS 60%

5 yr OS.
DFS: disease free survival.
′: Median survival.